EU Reports Highlight Urgency Of Rethinking Drug Investment And Procurement Reform

Medicines For Europe Has Called For Clearer Legal Guidance On Generic And Biosimilar Policies

 
• By Chloe Kent

Medicines for Europe has responded to two recent publications from the European Commission, calling for policy reforms to support the role of generic and biosimilar medicines.

Question mark of yellow stars against blue background
Medicines for Europe has urged the EU to rethink investment and reform procurement in favor of off-patent drugs • Source: Shutterstock

More from Europe

More from Geography